Tara Tainton – FOR MEN ONLY: New Clinical Trial Seeks Male Volunteers
The primary objective for this study is to evaluate the safety of and record the full effects of a new human growth hormone for men. The study is randomized, vehicle-controlled, ascending multiple dose, placebo-controlled, clinical proof-of-concept, phase 2 study to evaluate the safety, efficacy, tolerability, pharmacokinetics, pharmacodynamics, and physiological effects of Virilimax® administered subcutaneously in adult male patients. Full nudity of volunteers is required. (Note: All nurse practitioners involved in carrying out the methods of the study are professionals, and any inappropriate behavior by volunteers will not be tolerated. Volunteers will be provided with a digital copy of the 542-page disclosure document listing all possible side effects.)
